Why the study?
Predictors of prognosis in patients undergoing transcatheter tricuspid valve replacement (TTVR) remain to be defined.
Answers are grounded in this paper and cite their sources.
Advanced RV dysfunction and precapillary pulmonary hypertension should be carefully evaluated before TTVR to avoid post-procedural RV failure and adverse outcomes.
ascites was observed in 20–50%, suggesting advanced right heart failure (HF). In patients undergoing TV surgery, delayed operative intervention in patients with RV dysfunction and end-organ damage including renal and hepatic dysfunction negatively impacts perioperative outcomes (6). However, predictors of prognosis in patients undergoing TTVR remain to be defined. The recent real-world European commercial EVOQUE registry demonstrated that preoperative RV dysfunction was associated not only with adverse short-term outcomes including in-hospital mortality but also with reduced clinical improvement at follow-up (7). This would suggest that TTVR is best avoided in patients with advanced RV dysfunction, with likely preference for tricuspid transcatheter edge-to-edge repair (TEER) given it rarely abolishes TR. In addition, invasive hemodynamic assessment to exclude precapillary pulmonary hypertension and/or pulmonary vascular resistance >5 WU is important to avoid post-TTVR afterload mismatch and RV failure. The pulmonary artery (PA) to RV coupling index, assessed either non-invasively measured as PA systolic pressure divided by tricuspid annular plane systolic excursion (TAPSE) ( ≤ 0.406) (8) or invasively measured as PA systolic pressure/TAPSE ratio (<0.303) (9), has been linked to worse outcomes in patients undergoing TEER, and likely also
No takes yet. Share an insight, caveat, or question.
Fam et al. (2026) conducted an editorial in Tricuspid regurgitation. Transcatheter tricuspid valve replacement (TTVR) vs. Medical therapy or transcatheter edge-to-edge repair (TEER) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: